Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
NEW YORK (Reuters Health) – The outcome of treatment for early prostate cancer depends on the patient’s sexual, bowel and urinary function at baseline. These factors also influence…
NEW YORK (Reuters Health) – A network of altered genes appears to play a key role in the pathogenesis of gliomas, according to a report in the Journal…
NEW YORK (Reuters Health) – Although capsule endoscopy (PillCam COLON Capsule; Given Imaging) provides visualization of the colonic mucosa, it is not as sensitive as standard colonoscopy for…
A new tool in the fight against Barrett’s Esophagus shows promise. A recent study by Dr. Nicholas Shaheen, director of the University of North Carolina Center for Functional…
NEW YORK (Reuters Health) – Transvaginal sonography (TVS) is superior to symptom analysis for detecting ovarian cancer, while symptom analysis is better able to distinguish benign tumors, according…
NEW YORK (Reuters Health) – New research suggests that regardless of how hormone therapy is given, it increases the risk of ovarian cancer. “Our study suggests an increased…
July 14, 2009 (Portland, Ore.) – One in eight women develop breast cancer in their lifetimes. Although regular mammograms can reduce breast cancer deaths by more than 30…
NEW YORK (Reuters Health) – A further analysis of data from the Women’s Health Initiative (WHI) trials indicates that the risks of hormone therapy still generally outweigh the…
